Excellent update, things are ticking along nicely, strong interest from the UK, Germany and the US,
FDA ,, expect to be a class 1 medical device, approval by year end
Peer reviews, two more in the final stages of editorial
It just gets better
Going to be a interesting end to the year
DD
